GlaxoSmithKline is improving process efficiency in the production of pharmaceutical powders at its “centre of excellence” plant in Dartford, Kent, by investing in nine new industrial pharmaceutical sieves fitted with the Vibrasonic® Deblinding System from Russell Finex.
As an international organization that provides for the global market, SHL is excited to announce the addition of Spanish – one of the most prolific languages in the world – to the company’s corporate website. This brings the total number of supported languages to eight, including English, German, French, Japanese, Chinese (Traditional and Simplified) and Korean.
Responding to the rapid growth and expansion of SHL Group around the globe, a new management structure has been introduced to the company to further optimize internal operations and allow for clearer boundaries and scopes of responsibility. With this change came the introduction of SHL’s newly consolidated core company values, which further emphasizes SHL’s dedication to customers and employees alike.
Within just two years of reaching a milestone of 2,500 employees, SHL Group has rapidly reached 3,000 employees worldwide. This increase is reflective of a steady yet rapid growth in the injectable drug delivery market and SHL’s effective commitment, productivity and management.
As a company that develops and manufactures equipment solutions for home, hospital, and long-term care use with a focus on patient comfort and functionality, SHL Healthcare provides a broad range of products, including robust mattress systems. To help users better understand how to replace a mattress, we have provided the quick setup video.
With rapid growth of SHL Group and along with new innovations and technologies developed for pen and auto injectors, the Taoyuan facility requires expansion of space, and thus will be relocating to a the new site in Nankan, Taoyuan. Construction started in Q4 of 2015 and completion of the building is expected to be in Q4 of 2017.
With a newly designed booth to reflect SHL’s Scandinavian roots, SHL not only brought to this year’s PDA a booth with a welcoming vibe, but also created much buzz around the newly introduced Penny™ Pen injector, as well as the Molly® 2.25 Auto Injector and Alubena™ – a program dedicated to connectivity based innovations for drug delivery systems.
This year is a special one for Vaisala as we celebrate our 80-year anniversary. Throughout the past decades, Vaisala has been driven by a passion for creating the world’s finest environmental measurement solutions.
To stay innovative and competitive as a leading provider in advanced drug delivery devices such as auto injectors and pen injectors, SHL continuously invests in developing new pragmatic products that reflect industry trends and end-user needs. Most recent examples include the higher volume auto injector, Molly® 2.25, as well as Molly®C – a connected device that responds to the definitive trend amid widespread use of the internet. Both devices are based on the well-known Molly® auto injector, a 2-step device that revolutionized the industry with its simplicity, ease-of-use and compactness.
An inevitable trend we observe today is the adoption of the Internet of things. Along with the widespread of connected technologies, opportunities have continued to emerge for various industries. With the pharmaceutical industry experiencing a paradigm shift, where focus is turning from specific drugs to patient outcomes, opportunities like this allow for integration of medical devices and connectivity to further support patient compliance through better guidance, tracking and more.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.